Regencell Bioscience Limited(RGC)

POST5.500.000.00%19:30 EDT

5.50-0.04-0.72%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
Regencell Bioscience Limited
Market
NASDAQ
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.regencellbioscience.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
- 2025-10-31
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-10-25
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2023-10-28
  Annual Report
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-10-31
  Annual Report
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-07-26
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2022-05-16
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2022-04-04
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2021-12-30
  Beneficial Ownership Change
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
  SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
- 2021-12-15
  Beneficial Ownership Change
  SC 13G - Statement of acquisition of beneficial ownership by individuals
  SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2021-07-13
  Correspondence
  CORRESP [Cover] - Correspondence
  CORRESP [Cover] - Correspondence
- 2021-07-13
  Correspondence
  CORRESP [Cover] - Correspondence
  CORRESP [Cover] - Correspondence
- 2021-07-08
  [Supp]Public Prospectus
  FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2021-06-30
  [Supp]Public Prospectus
  FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2021-06-23
  [Amend]Public Prospectus
  F-1/A [Amend] - Registration statement for certain foreign private issuers
  F-1/A [Amend] - Registration statement for certain foreign private issuers
- 2021-06-22
  Correspondence
  CORRESP [Cover] - Correspondence
  CORRESP [Cover] - Correspondence

1D
5D
Day
Week
Month

Loading ...

High

5.58

Open

5.53

Volume%

0.39

Low

5.40

5.54

T/O Rate

0.33%

To The Moon

Regencell Bioscience Limited(RGC)

Company Profile

Most Discussed